Cargando…

Follicular thyroid carcinoma: differences in clinical relevance between minimally invasive and widely invasive tumors

BACKGROUND: Evidence on the biological behavior and clinical courses of minimally invasive and widely invasive follicular thyroid carcinoma (MI-FTC, WI-FTC) is still debatable. The current study was conducted to identify differences between MI and WI tumors and those prognostic parameters influencin...

Descripción completa

Detalles Bibliográficos
Autores principales: Podda, Mauro, Saba, Alessandra, Porru, Federica, Reccia, Isabella, Pisanu, Adolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458056/
https://www.ncbi.nlm.nih.gov/pubmed/26041024
http://dx.doi.org/10.1186/s12957-015-0612-8
_version_ 1782375051894456320
author Podda, Mauro
Saba, Alessandra
Porru, Federica
Reccia, Isabella
Pisanu, Adolfo
author_facet Podda, Mauro
Saba, Alessandra
Porru, Federica
Reccia, Isabella
Pisanu, Adolfo
author_sort Podda, Mauro
collection PubMed
description BACKGROUND: Evidence on the biological behavior and clinical courses of minimally invasive and widely invasive follicular thyroid carcinoma (MI-FTC, WI-FTC) is still debatable. The current study was conducted to identify differences between MI and WI tumors and those prognostic parameters influencing late outcome such as local recurrence and survival. METHODS: From January 1998 to October 2013, 71 patients were operated on in our department because of a FTC. A retrospective cohort study was carried out to compare 42 MI-FTC and 29 WI-FTC. The comparison involved evaluation of patient characteristics, tumor characteristics, tumor staging, and risk assessment. RESULTS: A diameter greater than 4.0 cm, the presence of vascular invasion, the TNM stage III–IVA, and the high risk at AMES system risk stratification were independent factors significantly related to the presence of a WI-FTC. The only independent predictor of recurrence and disease-free survival at 10-year follow-up was a tumor size greater than 4.0 cm. CONCLUSIONS: More attention must be paid in the postoperative tumor re-staging of those patients with tumor size larger than 4.0 cm, which was the only parameter predicting recurrence and influencing disease-free survival. Nevertheless, definitive recommendations cannot be made without a longer follow-up.
format Online
Article
Text
id pubmed-4458056
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44580562015-06-07 Follicular thyroid carcinoma: differences in clinical relevance between minimally invasive and widely invasive tumors Podda, Mauro Saba, Alessandra Porru, Federica Reccia, Isabella Pisanu, Adolfo World J Surg Oncol Research BACKGROUND: Evidence on the biological behavior and clinical courses of minimally invasive and widely invasive follicular thyroid carcinoma (MI-FTC, WI-FTC) is still debatable. The current study was conducted to identify differences between MI and WI tumors and those prognostic parameters influencing late outcome such as local recurrence and survival. METHODS: From January 1998 to October 2013, 71 patients were operated on in our department because of a FTC. A retrospective cohort study was carried out to compare 42 MI-FTC and 29 WI-FTC. The comparison involved evaluation of patient characteristics, tumor characteristics, tumor staging, and risk assessment. RESULTS: A diameter greater than 4.0 cm, the presence of vascular invasion, the TNM stage III–IVA, and the high risk at AMES system risk stratification were independent factors significantly related to the presence of a WI-FTC. The only independent predictor of recurrence and disease-free survival at 10-year follow-up was a tumor size greater than 4.0 cm. CONCLUSIONS: More attention must be paid in the postoperative tumor re-staging of those patients with tumor size larger than 4.0 cm, which was the only parameter predicting recurrence and influencing disease-free survival. Nevertheless, definitive recommendations cannot be made without a longer follow-up. BioMed Central 2015-06-04 /pmc/articles/PMC4458056/ /pubmed/26041024 http://dx.doi.org/10.1186/s12957-015-0612-8 Text en © Podda et al. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Podda, Mauro
Saba, Alessandra
Porru, Federica
Reccia, Isabella
Pisanu, Adolfo
Follicular thyroid carcinoma: differences in clinical relevance between minimally invasive and widely invasive tumors
title Follicular thyroid carcinoma: differences in clinical relevance between minimally invasive and widely invasive tumors
title_full Follicular thyroid carcinoma: differences in clinical relevance between minimally invasive and widely invasive tumors
title_fullStr Follicular thyroid carcinoma: differences in clinical relevance between minimally invasive and widely invasive tumors
title_full_unstemmed Follicular thyroid carcinoma: differences in clinical relevance between minimally invasive and widely invasive tumors
title_short Follicular thyroid carcinoma: differences in clinical relevance between minimally invasive and widely invasive tumors
title_sort follicular thyroid carcinoma: differences in clinical relevance between minimally invasive and widely invasive tumors
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458056/
https://www.ncbi.nlm.nih.gov/pubmed/26041024
http://dx.doi.org/10.1186/s12957-015-0612-8
work_keys_str_mv AT poddamauro follicularthyroidcarcinomadifferencesinclinicalrelevancebetweenminimallyinvasiveandwidelyinvasivetumors
AT sabaalessandra follicularthyroidcarcinomadifferencesinclinicalrelevancebetweenminimallyinvasiveandwidelyinvasivetumors
AT porrufederica follicularthyroidcarcinomadifferencesinclinicalrelevancebetweenminimallyinvasiveandwidelyinvasivetumors
AT recciaisabella follicularthyroidcarcinomadifferencesinclinicalrelevancebetweenminimallyinvasiveandwidelyinvasivetumors
AT pisanuadolfo follicularthyroidcarcinomadifferencesinclinicalrelevancebetweenminimallyinvasiveandwidelyinvasivetumors